<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Doses</title>
	<atom:link href="https://www.worldpharmatoday.com/topics/doses/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.worldpharmatoday.com</link>
	<description>Magazine for the C-level Pharma Executives</description>
	<lastBuildDate>Fri, 04 Sep 2026 10:11:10 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1</generator>

<image>
	<url>https://www.worldpharmatoday.com/wp-content/uploads/2025/12/cropped-World-Pharma-Today-fevicon-32x32.jpg</url>
	<title>Doses</title>
	<link>https://www.worldpharmatoday.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Why More Data Doesn&#8217;t Automatically Mean Better AI in Drug Discovery</title>
		<link>https://www.worldpharmatoday.com/articles/why-more-data-doesnt-automatically-mean-better-ai-in-drug-discovery/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 17 Aug 2026 07:18:26 +0000</pubDate>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Doses]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/why-more-data-doesnt-automatically-mean-better-ai-in-drug-discovery/</guid>

					<description><![CDATA[<p>When DeciBio asked nine senior pharma executives what was holding back AI adoption in R&#38;D, the answer wasn&#8217;t algorithms or compute. Three of the top four barriers they named were data problems, and low-quality data was cited by every single one of them. Every AI drug discovery pitch deck has a slide about proprietary data. [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/articles/why-more-data-doesnt-automatically-mean-better-ai-in-drug-discovery/">Why More Data Doesn’t Automatically Mean Better AI in Drug Discovery</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Controlled Release Drug Formulations Shaping Patient Care</title>
		<link>https://www.worldpharmatoday.com/drug-research/controlled-release-drug-formulations-shaping-patient-care/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 06 Feb 2026 10:25:23 +0000</pubDate>
				<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Drug Research]]></category>
		<category><![CDATA[Health & Wellness]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<category><![CDATA[Doses]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/controlled-release-drug-formulations-shaping-patient-care/</guid>

					<description><![CDATA[<p>An exploration of how advanced dosing mechanisms maintain therapeutic stability, reduce side effects, and improve patient compliance in the management of chronic conditions.</p>
The post <a href="https://www.worldpharmatoday.com/drug-research/controlled-release-drug-formulations-shaping-patient-care/">Controlled Release Drug Formulations Shaping Patient Care</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Bora &#8211; Corealis Collaborate for Oral Solid Dose Development</title>
		<link>https://www.worldpharmatoday.com/news/bora-corealis-collaborate-for-oral-solid-dose-development/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 15 Dec 2025 08:57:47 +0000</pubDate>
				<category><![CDATA[BioPharma]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Production & Manufacturing]]></category>
		<category><![CDATA[Biopharma Businesses]]></category>
		<category><![CDATA[Doses]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/bora-corealis-collaborate-for-oral-solid-dose-development/</guid>

					<description><![CDATA[<p>Bora Pharmaceuticals Co. Ltd., which is a global leader when it comes to pharmaceutical manufacturing, along with a leading early-phase Contract Development Manufacturing Organization – CDMO, Corealis Pharma Inc., have gone on to enter into a strategic alliance so as to offer end-to-end services for oral solid dose development as well as manufacturing. The partnership [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/news/bora-corealis-collaborate-for-oral-solid-dose-development/">Bora – Corealis Collaborate for Oral Solid Dose Development</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
